Because both ARG1 and IDO1 act as immune checkpoint mechanisms in neoplasia, their functional “alliance” in specific immune cells could be remarkably effective in controlling adaptive immunity toward auto-antigens. The gene discussed is ARG1; the disease is neoplasm.